Ameriprise Financial Inc. Grows Holdings in Vital Farms, Inc. (NASDAQ:VITL)

Ameriprise Financial Inc. grew its position in Vital Farms, Inc. (NASDAQ:VITL - Free Report) by 25.2% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 84,592 shares of the company's stock after purchasing an additional 17,017 shares during the quarter. Ameriprise Financial Inc. owned approximately 0.19% of Vital Farms worth $3,188,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of VITL. Barclays PLC boosted its stake in shares of Vital Farms by 57.3% in the 3rd quarter. Barclays PLC now owns 95,444 shares of the company's stock valued at $3,347,000 after purchasing an additional 34,758 shares during the last quarter. Spire Wealth Management boosted its stake in shares of Vital Farms by 66.2% in the 4th quarter. Spire Wealth Management now owns 11,800 shares of the company's stock valued at $445,000 after purchasing an additional 4,700 shares during the last quarter. Values First Advisors Inc. bought a new stake in shares of Vital Farms in the 4th quarter valued at $199,000. Van ECK Associates Corp boosted its stake in shares of Vital Farms by 112.8% in the 4th quarter. Van ECK Associates Corp now owns 5,579 shares of the company's stock valued at $210,000 after purchasing an additional 2,957 shares during the last quarter. Finally, Vontobel Holding Ltd. bought a new position in Vital Farms during the fourth quarter worth $298,000. 98.59% of the stock is owned by institutional investors.

Insider Activity at Vital Farms

In other news, CEO Russell Diez-Canseco sold 45,124 shares of the business's stock in a transaction that occurred on Monday, April 14th. The shares were sold at an average price of $33.69, for a total value of $1,520,227.56. Following the completion of the sale, the chief executive officer now directly owns 703,736 shares in the company, valued at approximately $23,708,865.84. The trade was a 6.03% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Matthew Ohayer sold 20,000 shares of the company's stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $29.46, for a total transaction of $589,200.00. Following the sale, the insider now owns 6,970,890 shares of the company's stock, valued at $205,362,419.40. This represents a 0.29% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 93,124 shares of company stock valued at $3,019,308. Corporate insiders own 27.60% of the company's stock.

Vital Farms Stock Up 0.9%

Shares of VITL traded up $0.29 during trading hours on Friday, reaching $32.24. 984,081 shares of the stock traded hands, compared to its average volume of 1,027,530. The company has a current ratio of 3.24, a quick ratio of 2.81 and a debt-to-equity ratio of 0.04. The stock has a fifty day simple moving average of $33.36 and a 200 day simple moving average of $35.13. Vital Farms, Inc. has a 52 week low of $27.91 and a 52 week high of $48.41. The company has a market cap of $1.44 billion, a price-to-earnings ratio of 28.79 and a beta of 0.94.

Vital Farms (NASDAQ:VITL - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.26 by $0.11. The firm had revenue of $162.19 million during the quarter, compared to the consensus estimate of $164.43 million. Vital Farms had a net margin of 8.68% and a return on equity of 22.29%. The company's revenue was up 9.7% on a year-over-year basis. During the same quarter last year, the company earned $0.43 earnings per share. On average, equities analysts forecast that Vital Farms, Inc. will post 1.11 EPS for the current year.

Analysts Set New Price Targets

Several brokerages recently issued reports on VITL. BMO Capital Markets raised shares of Vital Farms to a "strong-buy" rating in a research note on Tuesday, May 6th. DA Davidson cut their target price on shares of Vital Farms from $44.00 to $42.00 and set a "buy" rating on the stock in a research note on Friday, March 14th. Morgan Stanley cut their target price on shares of Vital Farms from $40.00 to $39.00 and set an "overweight" rating on the stock in a research note on Thursday, April 17th. William Blair reissued an "outperform" rating on shares of Vital Farms in a research note on Friday, February 28th. Finally, Telsey Advisory Group reissued an "outperform" rating and set a $52.00 target price on shares of Vital Farms in a research note on Monday, May 5th. Eight equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Buy" and an average price target of $44.63.

Vital Farms Company Profile

Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.